Rational design of a classical swine fever C-strain vaccine virus that enables the differentiation between infected and vaccinated animals.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Virological Methods

• Publication date

  2010-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jviromet.2009.09.012PMID 19770004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Virus evolution as a tool to study HIV-1 biology.

  2009cited by this paper
• Development of a live attenuated antigenic marker classical swine fever vaccine.

  2009cited by this paper
• Hepatitis C Virus NS2 Protein Contributes to Virus Particle Assembly via Opposing Epistatic Interactions with the E1-E2 Glycoprotein and NS3-NS4A Enzyme Complexes

  2009cited by this paper
• Identification of a conserved linear B-cell epitope at the N-terminus of the E2 glycoprotein of Classical swine fever virus by phage-displayed random peptide library.

  2008cited by this paper
• Chimeric pestiviruses: candidates for live-attenuated classical swine fever marker vaccines.

  2007cited by this paper
• CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV).

  2007cited by this paper
• Novel marker vaccines against classical swine fever.

  2007cited by this paper
• Identification of a novel virulence determinant within the E2 structural glycoprotein of classical swine fever virus.

  2006cited by this paper
• Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV.

  2005cited by this paper
• Virus taxonomy : eighth report of the International Committee on Taxonomy of Viruses

  2005cited by this paper
• An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus.

  2004cited by this paper
• Vaccinology of classical swine fever: from lab to field.

  2003cited by this paper
• Suitability of an E2 subunit vaccine of classical swine fever in combination with the E(rns)-marker-test for eradication through vaccination.

  2003cited by this paper
• Vaccinology of classical swine fever: from lab to field

  2003cited by this paper
• Suitability of an E2 subunit vaccine of classical swine fever in combination with the E(rns)-marker-test for eradication through vaccination.

  2003cited by this paper
• Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV.

  2002cited by this paper
• Classical swine fever (CSF) marker vaccine. Trial II. Challenge study in pregnant sows.

  2001cited by this paper
• Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs.

  2001cited by this paper
• Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs.

  2001cited by this paper
• Classical Swine Fever Virus ErnsDeletion Mutants: trans-Complementation and Potential Use as Nontransmissible, Modified, Live-Attenuated Marker Vaccines

  2000cited by this paper
• Recombinant classical swine fever (CSF) viruses derived from the Chinese vaccine strain (C-strain) of CSF virus retain their avirulent and immunogenic characteristics.

  2000cited by this paper
• Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response.

  2000cited by this paper
• The 1997/1998 epizootic of swine fever in the Netherlands: control strategies under a non-vaccination regimen.

  2000cited by this paper
• Deletions of Structural Glycoprotein E2 of Classical Swine Fever Virus Strain Alfort/187 Resolve a Linear Epitope of Monoclonal Antibody WH303 and the Minimal N-Terminal Domain Essential for Binding Immunoglobulin G Antibodies of a Pig Hyperimmune Serum

  2000cited by this paper
• Recovery of infectious classical swine fever virus (CSFV) from full-length genomic cDNA clones by a swine kidney cell line expressing bacteriophage T7 RNA polymerase.

  1999cited by this paper
• Subdivision of the pestivirus genus based on envelope glycoprotein E2.

  1997cited by this paper
• Structural aspects of antibody-antigen interaction revealed through small random peptide libraries

  1996cited by this paper
• Infectious RNA transcribed from an engineered full-length cDNA template of the genome of a pestivirus

  1996cited by this paper
• Antigenic structure of envelope glycoprotein E1 of hog cholera virus

  1994cited by this paper
• Epitope mapping of envelope glycoprotein E1 of hog cholera virus strain Brescia.

  1993cited by this paper
• Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera

  1993cited by this paper
• Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera

  1991cited by this paper
• Hog cholera virus: molecular composition of virions from a pestivirus

  1991cited by this paper
• The development of an international reference panel of monoclonal antibodies for the differentiation of hog cholera virus from other pestiviruses.

  1991cited by this paper
• Topographical and functional mapping of epitopes on hog cholera virus with monoclonal antibodies.

  1989cited by this paper
• The protective value of vaccine-induced neutralising antibody titres in swine fever.

  1988cited by this paper
• Assembly of asparagine-linked oligosaccharides.

  1985cited by this paper

• Different Types of Vaccines against Pestiviral Infections: “Barriers” for “Pestis”

  2022cites this paper
• Safety, efficacy, and DIVA feasibility on a novel live attenuated CSFV marker vaccine candidate.

  2022cites this paper
• Research Progress and Challenges in Vaccine Development against Classical Swine Fever Virus

  2021cites this paper
• Development of a Dendrimeric Peptide-Based Approach for the Differentiation of Animals Vaccinated with FlagT4G against Classical Swine Fever from Infected Pigs

  2021cites this paper
• Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever

  2021cites this paper
• Seroprevalence of the viral pig diseases among backyard pigs in Chiang Mai, Thailand.

  2021cites this paper
• Vector competence is strongly affected by a small deletion or point mutations in bluetongue virus

  2019cites this paper
• An improved indirect ELISA for specific detection of antibodies against classical swine fever virus based on structurally designed E2 protein expressed in suspension mammalian cells

  2018cites this paper
• Classical swine fever vaccines-State-of-the-art.

  2017cites this paper
• Detección mediante RT-PCR en tiempo real del virus vacunal en cerdos inmunizados con la vacuna cubana contra la peste porcina clásica

  2016cites this paper
• The Epitope Recognized by Monoclonal Antibody 2B6 in the B/C Domains of Classical Swine Fever Virus Glycoprotein E2 Affects Viral Binding to Hyperimmune Sera and Replication.

  2015cites this paper
• Structures and Functions of Pestivirus Glycoproteins: Not Simply Surface Matters

  2015cites this paper
• Discrimination within epitope specific antibody populations against Classical swine fever virus is a new means of differentiating infection from vaccination.

  2015cites this paper
• jmbReview The Epitope Recognized by Monoclonal Antibody 2 B 6 in the B / C Domains of Classical Swine Fever Virus Glycoprotein E 2 Affects Viral Binding to Hyperimmune Sera and Replication

  2015cites this paper
• Classical swine fever in pigs: recent developments and future perspectives

  2014cites this paper
• The challenges of classical swine fever control: modified live and E2 subunit vaccines.

  2014cites this paper
• Structural models of the membrane anchors of envelope glycoproteins E1 and E2 from pestiviruses

  2014influential citation
• Preliminary mapping of non-conserved epitopes on envelope glycoprotein E2 of Bovine viral diarrhea virus type 1 and 2.

  2013cites this paper
• [Possibilities and limitations in veterinary vaccine development using the example of classical swine fever].

  2013cites this paper
• Construction of a Chimeric Classical Swine Fever Virus C-strain Containing E2 of Group II Isolate Remains and Its Biological Characteristics

  2013cites this paper
• Review of Different Strategies for Preventing and Controlling Classical Swine Fever

  2012cites this paper
• Review of Different Strategies for Preventing and Controlling Classical Swine Fever

  2012cites this paper
• Antigenic mimicking with cysteine-based cyclized peptides reveals a previously unknown antigenic determinant on E2 glycoprotein of classical swine fever virus.

  2012cites this paper
• Characterization of C-strain “Riems” TAV-epitope escape variants obtained through selective antibody pressure in cell culture

  2012cites this paper
• Identification of conformational epitopes and antigen-specific residues at the D/A domains and the extramembrane C-terminal region of E2 glycoprotein of classical swine fever virus.

  2012cites this paper
• Protective efficacy of a Classical swine fever virus C-strain deletion mutant and ability to differentiate infected from vaccinated animals.

  2011cites this paper
• Identification of antigen-specific residues on E2 glycoprotein of classical swine fever virus.

  2010cites this paper
• Antigenic domains analysis of classical swine fever virus E2 glycoprotein by mutagenesis and conformation-dependent monoclonal antibodies.

  2010cites this paper